Veraxa Biotech AG financial statements
Veraxa Biotech AG's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | CHF 23.43K | EODHD |
| Net income | −CHF 66.61M | EODHD |
| Cash and equivalents | CHF 1.61M | EODHD |
Veraxa Biotech AG financials on 6ix · Veraxa Biotech AG on 6ix